OAC
IRD

OMERS Administration Corp’s Opus Genetics IRD Stock Holding History

OMERS Administration Corp’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$189K Sell
41,600
-46,300
-53% -$160K ﹤0.01% 928
2025
Q4 		$177K Buy
+87,900
New +$178K ﹤0.01% 925

Other funds holding IRD

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

OMERS Administration Corp's IRD Position: Q1 2026 in Review

OMERS Administration Corp reduced its Opus Genetics (IRD) stake by 53% in Q1 2026, selling an estimated $160K and leaving 41,600 shares worth $189K. The position accounts for ﹤0.01% of the portfolio, ranked #928.

OMERS Administration Corp first reported a position in IRD in Q4 2025 and has held it in 2 quarters since. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

  • OMERS Administration Corp held 41,600 shares of Opus Genetics worth $189K as of Q1 2026.
  • OMERS Administration Corp sold 46,300 Opus Genetics shares in Q1 2026, an estimated $160K.
  • Opus Genetics made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #928 holding.
  • OMERS Administration Corp first reported a position in Opus Genetics in Q4 2025 and has held it in 2 quarters since.
  • 79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.